A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-week carboplatin and weekly paclitaxel in advanced non-small cell lung cancer

収録刊行物

• Ann Oncol

  Ann Oncol 17 104-109, 2006